Published in Proc Natl Acad Sci U S A on February 13, 2008
Neuronal autoantigens--pathogenesis, associated disorders and antibody testing. Nat Rev Neurol (2012) 3.20
A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief. Cell (2014) 1.99
Neurological perspectives on voltage-gated sodium channels. Brain (2012) 1.62
Production of a specific extracellular inhibitor of TRPM3 channels. Br J Pharmacol (2008) 1.13
VGCC antibody-positive paraneoplastic cerebellar degeneration presenting with positioning vertigo. Neurol Sci (2011) 0.97
'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC. J Neuroinflammation (2015) 0.92
Physiologic alterations in ataxia: channeling changes into novel therapies. Arch Neurol (2009) 0.90
Paraneoplastic cerebellar degeneration associated with noncutaneous Merkel cell carcinoma. Neurol Neuroimmunol Neuroinflamm (2014) 0.81
Antibody therapeutics targeting ion channels: are we there yet? Acta Pharmacol Sin (2013) 0.80
Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physiol Rev (2017) 0.78
Autoimmune channelopathies of the nervous system. Curr Neuropharmacol (2011) 0.76
Safety of pregabalin among hemodialysis patients suffering from uremic pruritus. Saudi Pharm J (2015) 0.75
Characterization of a mouse model of headache. Pain (2016) 0.75
Neuronal central nervous system syndromes probably mediated by autoantibodies. Eur J Neurosci (2016) 0.75
Suppression of Medulloblastoma Lesions by Forced Migration of Preneoplastic Precursor Cells with Intracerebellar Administration of the Chemokine Cxcl3. Front Pharmacol (2016) 0.75
Immune-mediated cerebellar ataxias: from bench to bedside. Cerebellum Ataxias (2017) 0.75
Paraneoplastic syndromes involving the nervous system. N Engl J Med (2003) 5.46
Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. J Am Med Assoc (1957) 3.55
Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci (1995) 3.38
Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons. J Neurosci (1995) 3.07
Calcium control of transmitter release at a cerebellar synapse. Neuron (1995) 2.98
Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med (1995) 2.32
Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. Ann Neurol (2003) 2.28
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology (2002) 2.05
Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med (2000) 1.76
Structure and function of neuronal Ca2+ channels and their role in neurotransmitter release. Cell Calcium (1999) 1.75
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain (1997) 1.73
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A (1983) 1.71
Localization of P-type calcium channels in the central nervous system. Proc Natl Acad Sci U S A (1991) 1.71
Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology (1992) 1.41
Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet (1989) 1.33
Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin. Nature (1994) 1.19
Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc (1989) 1.16
Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci (1989) 1.12
Subacute cerebellar degeneration and Eaton-Lambert syndrome with bronchogenic carcinoma. A case report. Neurology (1973) 1.12
Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol (1999) 1.10
Inhibition of N- and L-type Ca2+ channels by the spider venom toxin omega-Aga-IIIA. Proc Natl Acad Sci U S A (1991) 1.04
Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Ann Neurol (1996) 1.03
Amino acid residues outside of the pore region contribute to N-type calcium channel permeation. J Biol Chem (2000) 0.98
Residue Gly1326 of the N-type calcium channel alpha 1B subunit controls reversibility of omega-conotoxin GVIA and MVIIA block. J Biol Chem (2001) 0.98
Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor. Muscle Nerve (1982) 0.98
Interactions among toxins that inhibit N-type and P-type calcium channels. J Gen Physiol (2002) 0.96
Calcium channel blockers and transmitter release at the normal human neuromuscular junction. Neurology (1996) 0.93
Block of Ca channels in rat central neurons by the spider toxin omega-Aga-IIIA. J Neurosci (1994) 0.93
P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer. J Neuroimmunol (2005) 0.92
Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons. Proc Natl Acad Sci U S A (1998) 0.90
Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons. Proc Natl Acad Sci U S A (1996) 0.84
Distinctive properties of a neuronal calcium channel and its contribution to excitatory synaptic transmission in the central nervous system. Adv Second Messenger Phosphoprotein Res (1994) 0.82
Autoimmunity and neurological disease: antibody modulation of synaptic transmission. Annu Rev Neurosci (1999) 0.82
Recombinant calcium channel is recognized by Lambert-Eaton myasthenic syndrome antibodies. Neurology (2000) 0.80
Immunopathology of the Lambert-Eaton myasthenic syndrome. Springer Semin Immunopathol (1995) 0.80
Linear B-cell epitopes in Lambert-Eaton myasthenic syndrome defined by cell-free synthetic peptide binding. J Neuroimmunol (2002) 0.80
Expression and antibody inhibition of P-type calcium channels in human small-cell lung carcinoma cells. J Neurosci (1995) 0.79
Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome? Ann Neurol (2003) 0.77
Lambert-Eaton myasthenic syndrome. Antigenicity of recombinant human P/Q-type calcium channel alpha 1 subunit putative ion pore region (domain IV, S5-S6). Ann N Y Acad Sci (1998) 0.77
Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer. Am Rev Respir Dis (1993) 0.77
Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats. J Neurol Sci (1999) 0.77
High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature (2010) 8.37
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med (2007) 7.73
Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med (2003) 6.73
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature (2002) 6.58
IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol (2008) 6.41
Multiple-color optical activation, silencing, and desynchronization of neural activity, with single-spike temporal resolution. PLoS One (2007) 5.98
MicroRNA-mediated conversion of human fibroblasts to neurons. Nature (2011) 5.59
Millisecond-timescale optical control of neural dynamics in the nonhuman primate brain. Neuron (2009) 5.50
Channelrhodopsin-2 and optical control of excitable cells. Nat Methods (2006) 5.46
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature (2002) 5.24
Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med (2004) 5.13
A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing. Nat Neurosci (2012) 4.87
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci U S A (2004) 4.75
Adaptation to synaptic inactivity in hippocampal neurons. Neuron (2005) 4.58
Induction and molecular signature of pathogenic TH17 cells. Nat Immunol (2012) 4.43
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature (2007) 3.92
Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol (2009) 3.88
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature (2008) 3.48
The dynamic control of kiss-and-run and vesicular reuse probed with single nanoparticles. Science (2009) 3.34
Activation of specific interneurons improves V1 feature selectivity and visual perception. Nature (2012) 3.27
Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol (2006) 3.21
Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat Med (2007) 3.09
CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. J Immunol (2005) 2.83
alpha- and betaCaMKII. Inverse regulation by neuronal activity and opposing effects on synaptic strength. Neuron (2002) 2.76
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest (2006) 2.75
Nanotools for neuroscience and brain activity mapping. ACS Nano (2013) 2.74
A high-light sensitivity optical neural silencer: development and application to optogenetic control of non-human primate cortex. Front Syst Neurosci (2011) 2.72
Frequency-dependent kinetics and prevalence of kiss-and-run and reuse at hippocampal synapses studied with novel quenching methods. Neuron (2006) 2.65
Calcium Green FlAsH as a genetically targeted small-molecule calcium indicator. Nat Chem Biol (2007) 2.47
CaMKII tethers to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ signals for facilitation. J Cell Biol (2005) 2.47
Signaling from synapse to nucleus: the logic behind the mechanisms. Curr Opin Neurobiol (2003) 2.42
Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science (2005) 2.41
A wirelessly powered and controlled device for optical neural control of freely-behaving animals. J Neural Eng (2011) 2.39
Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2004) 2.34
Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med (2005) 2.31
TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep (2012) 2.20
Optogenetic tools for analyzing the neural circuits of behavior. Trends Cogn Sci (2011) 2.15
Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A (2010) 2.14
Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity (2011) 2.11
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci U S A (2009) 2.07
Activity-induced rapid synaptic maturation mediated by presynaptic cdc42 signaling. Neuron (2006) 1.99
Automated whole-cell patch-clamp electrophysiology of neurons in vivo. Nat Methods (2012) 1.99
Optogenetically induced behavioral and functional network changes in primates. Curr Biol (2012) 1.95
The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proc Natl Acad Sci U S A (2008) 1.95
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med (2007) 1.93
Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. Mol Ther (2011) 1.91
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med (2013) 1.88
A gene-fusion strategy for stoichiometric and co-localized expression of light-gated membrane proteins. Nat Methods (2011) 1.87
Multiwaveguide implantable probe for light delivery to sets of distributed brain targets. Opt Lett (2010) 1.84
Selective engagement of plasticity mechanisms for motor memory storage. Neuron (2006) 1.82
The sequence of events that underlie quantal transmission at central glutamatergic synapses. Nat Rev Neurosci (2007) 1.82
Influence of synaptic vesicle position on release probability and exocytotic fusion mode. Science (2012) 1.81
Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest (2007) 1.67
Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J Immunol (2010) 1.66
Prosthetic systems for therapeutic optical activation and silencing of genetically-targeted neurons. Proc SPIE Int Soc Opt Eng (2008) 1.66
Drug discovery: a jump-start for electroceuticals. Nature (2013) 1.66
Tim-2 regulates T helper type 2 responses and autoimmunity. J Exp Med (2005) 1.63
CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation-transcription coupling. J Cell Biol (2008) 1.63
Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation. Sci Transl Med (2013) 1.62
TIM-4 expressed on APCs induces T cell expansion and survival. J Immunol (2008) 1.58
Three-dimensional multiwaveguide probe array for light delivery to distributed brain circuits. Opt Lett (2012) 1.58
Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. J Neurosci (2011) 1.58
Presynaptic Ca2+ channels compete for channel type-preferring slots in altered neurotransmission arising from Ca2+ channelopathy. Neuron (2004) 1.56
Characterization of the functional MRI response temporal linearity via optical control of neocortical pyramidal neurons. J Neurosci (2011) 1.56
Optogenetics and thermogenetics: technologies for controlling the activity of targeted cells within intact neural circuits. Curr Opin Neurobiol (2011) 1.55
Kiss-and-run and full-collapse fusion as modes of exo-endocytosis in neurosecretion. J Neurochem (2006) 1.55
Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons. Nature (2013) 1.54
Aberrant mitochondrial fission in neurons induced by protein kinase C{delta} under oxidative stress conditions in vivo. Mol Biol Cell (2010) 1.49
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion. Nat Med (2012) 1.48
Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J Exp Med (2007) 1.47
Synapse-specific adaptations to inactivity in hippocampal circuits achieve homeostatic gain control while dampening network reverberation. Neuron (2008) 1.45
Uncoupling dendrite growth and patterning: single-cell knockout analysis of NMDA receptor 2B. Neuron (2009) 1.45
Ca(V)1 and Ca(V)2 channels engage distinct modes of Ca(2+) signaling to control CREB-dependent gene expression. Cell (2012) 1.43
Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity. J Clin Invest (2006) 1.43
Physical principles for scalable neural recording. Front Comput Neurosci (2013) 1.40
LTP and adaptation to inactivity: overlapping mechanisms and implications for metaplasticity. Neuropharmacology (2006) 1.40
Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity. PLoS One (2012) 1.39
pHTomato, a red, genetically encoded indicator that enables multiplex interrogation of synaptic activity. Nat Neurosci (2012) 1.38
Face-selective electrostatic control of hydrothermal zinc oxide nanowire synthesis. Nat Mater (2011) 1.38
Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene (2004) 1.38
Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc Natl Acad Sci U S A (2012) 1.35
Perspectives on kiss-and-run: role in exocytosis, endocytosis, and neurotransmission. Annu Rev Physiol (2013) 1.35
Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. J Cereb Blood Flow Metab (2003) 1.35
Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels. Proc Natl Acad Sci U S A (2008) 1.34
Toward the second generation of optogenetic tools. J Neurosci (2010) 1.33
Optogenetic mimicry of the transient activation of dopamine neurons by natural reward is sufficient for operant reinforcement. PLoS One (2012) 1.32
Optogenetics and translational medicine. Sci Transl Med (2013) 1.31
Quantum dots provide an optical signal specific to full collapse fusion of synaptic vesicles. Proc Natl Acad Sci U S A (2007) 1.30
Altered properties of quantal neurotransmitter release at endplates of mice lacking P/Q-type Ca2+ channels. Proc Natl Acad Sci U S A (2003) 1.29
Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J Immunol (2005) 1.28
Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proc Natl Acad Sci U S A (2011) 1.26
Fusion pore modulation as a presynaptic mechanism contributing to expression of long-term potentiation. Philos Trans R Soc Lond B Biol Sci (2003) 1.25
Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc Natl Acad Sci U S A (2003) 1.23
Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits. Antimicrob Agents Chemother (2002) 1.22
Paired-pulse depression of unitary quantal amplitude at single hippocampal synapses. Proc Natl Acad Sci U S A (2004) 1.22
Measuring cation dependent DNA polymerase fidelity landscapes by deep sequencing. PLoS One (2012) 1.20
Development of a murine model of cerebral aspergillosis. J Infect Dis (2002) 1.19
Organization of beta-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes. J Cell Biol (2007) 1.19